Dr Simon Goldman

Dr Simon Goldman is an Investment Director of the UCL Technology Fund, which is dedicated to investing in intellectual property commercialisation opportunities arising from UCL’s world-class research base, focusing in particular on the physical and life sciences.

He has over a decade of experience investing in life sciences companies. After almost eight years at Goldman Sachs JBWere, Dr Goldman completed a neuroscience PhD and postdoc in Cambridge and subsequently worked for several years in the UK biotech start-up sector. He brings deep and diverse skills to management of life-science investing for the UCL Technology Fund. He is a director of Glialign and PanAngium Therapeutics.